Panacos Pharmaceuticals (Panacos Pharmaceuticals) Other Net Income (Loss) : $-35.76 Mil (TTM As of Sep. 2008)

View and export this data going back to 1998. Start your Free Trial

What is Panacos Pharmaceuticals Other Net Income (Loss)?

Panacos Pharmaceuticals's Other Net Income (Loss) for the three months ended in Sep. 2008 was $-8.15 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2008 was $-35.76 Mil.

Panacos Pharmaceuticals's quarterly Other Net Income (Loss) declined from Mar. 2008 ($-8.51 Mil) to Jun. 2008 ($-9.74 Mil) but then increased from Jun. 2008 ($-9.74 Mil) to Sep. 2008 ($-8.15 Mil).

Panacos Pharmaceuticals's annual Other Net Income (Loss) increased from Dec. 2005 ($-59.08 Mil) to Dec. 2006 ($-38.11 Mil) and increased from Dec. 2006 ($-38.11 Mil) to Dec. 2007 ($-37.46 Mil).

Panacos Pharmaceuticals Other Net Income (Loss) Historical Data

The historical data trend for Panacos Pharmaceuticals's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacos Pharmaceuticals Other Net Income (Loss) Chart

Panacos Pharmaceuticals Annual Data

Trend

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Other Net Income (Loss)

Get a 7-Day Free Trial

-4.51

-12.04

-59.08

-38.11

-37.46

Panacos Pharmaceuticals Quarterly Data
	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08
Other Net Income (Loss)	Get a 7-Day Free Trial															-7.91	-9.35	-8.51	-9.74	-8.15

Panacos Pharmaceuticals Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-35.76 Mil.

Panacos Pharmaceuticals Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Panacos Pharmaceuticals's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacos Pharmaceuticals Inc (GREY:PANC) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

134 Coolidge Avenue, Watertown, MA, USA, 02472

Website

http://www.panacos.com

Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Headlines

No Headlines